Gavin P. Robertson

Pennsylvania State University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

53h-index10.5kcitations279works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Melanoma and MAPK Pathways(44), Click Chemistry and Applications(40), Bioactive Compounds and Antitumor Agents(28), Cancer, Lipids, and Metabolism(25), Cancer Research and Treatments(25)

Publications279 total

Managing telomerase and telomere dysfunction in acral melanoma
Pharmacological Research·2025· 2 citedOpen Access
Novel Pan-ALDH Inhibitor KS100 Effectively Targets ALDH+/CD138⁻ Stem-like Cells to Overcome Relapse in Multiple Myeloma
2025Open Access
Modification of the telomerase gene with human regulatory sequences resets mouse telomeres to human length
Nature Communications·2025· 5 citedOpen Access
Emerging Role of the p53 Pathway in Modulating NK Cell–Mediated Immunity
Molecular Cancer Therapeutics·2024· 3 cited
Tumor Heterogeneity Shapes Survival Dynamics in Drug-Treated Cells, Revealing Size-Drifting Subpopulations
ACS Pharmacology & Translational Science·2024Open Access
Identification of Novel Isatin Derivative Bearing a Nitrofuran Moiety as Potent Multi-Isoform Aldehyde Dehydrogenase Inhibitor
Molecules·2024· 4 citedOpen Access
Pharmacological agents targeting drug-tolerant persister cells in cancer
Pharmacological Research·2024· 9 citedOpen Access
Humanization of the mouse telomerase gene reset telomeres to human length
2024· 1 citedOpen Access
Telomere dysfunction in Tert knockout mice delays <scp>Braf<sup>V600E</sup></scp>‐induced melanoma development
International Journal of Cancer·2023· 5 citedOpen Access
Supplementary Table 1 from Targeting Multiple Key Signaling Pathways in Melanoma Using Leelamine
2023Open Access
Data Supplement from Nanolipolee-007, a Novel Nanoparticle-Based Drug Containing Leelamine for the Treatment of Melanoma
2023Open Access
Supplemental Figure S6 from Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway
2023Open Access
Supplementary Figure 5 from Leelamine Mediates Cancer Cell Death through Inhibition of Intracellular Cholesterol Transport
2023Open Access
Supplementary Table 1 from Simultaneous Targeting of COX-2 and AKT Using Selenocoxib-1-GSH to Inhibit Melanoma
2023Open Access
Supplemental Figure S1 from Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway
2023Open Access
Supplemental Figure S5 from Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway
2023Open Access
Supplemental Figure S1 from Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway
2023Open Access
Supplementary Figure 5 from Leelamine Mediates Cancer Cell Death through Inhibition of Intracellular Cholesterol Transport
2023Open Access
Supplementary Figure Legend from Simultaneous Targeting of COX-2 and AKT Using Selenocoxib-1-GSH to Inhibit Melanoma
2023Open Access
Data from Disruption of Proline Synthesis in Melanoma Inhibits Protein Production Mediated by the GCN2 Pathway
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Arati Sharma(20), SubbaRao V. Madhunapantula(10), Raghavendra Gowda(8), Shantu Amin(6), Mark Kester(5), Arun Sharma(5), Omer F. Kuzu(4), Mitchell Cheung(4), Sung Jin Huh(4), Melissa Tran(4), Dhimant Desai(4), Mohammad A. Noory(3), Shile Liang(3), Cheng Dong(3), Charles D. Smith(3), Saketh S. Dinavahi(3), T G Lugo(3), Webster K. Cavenee(2), Jill M. Stahl(2), Melissa Zimmerman(2)